LRPA
LHDX
L. Roy Papp & Associates’s Lucira Health, Inc. Common Stock LHDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,699
| Closed | -$16.7K | – | 170 |
|
|
2022
Q4 | $16.7K | Buy |
150,699
+36,205
| +32% | +$4.02K | ﹤0.01% | 166 |
|
|
2022
Q3 | $121K | Sell |
114,494
-10,000
| -8% | -$10.6K | 0.02% | 161 |
|
|
2022
Q2 | $232K | Buy |
124,494
+16,489
| +15% | +$30.7K | 0.03% | 158 |
|
|
2022
Q1 | $386K | Buy |
108,005
+62,505
| +137% | +$223K | 0.05% | 140 |
|
|
2021
Q4 | $392K | Sell |
45,500
-350
| -0.8% | -$3.02K | 0.04% | 146 |
|
|
2021
Q3 | $348K | Buy |
+45,850
| New | +$348K | 0.04% | 149 |
|
|
2021
Q2 | – | Sell |
-45,350
| Closed | -$549K | – | 177 |
|
|
2021
Q1 | $549K | Buy |
+45,350
| New | +$549K | 0.08% | 118 |
|